Procambarus clarkii strain Jiangsu linkage group LG73, ASM2042438v2, whole genome shotgun sequence.
Procambarus clarkii (red swamp crayfish)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Astacidea; Astacoidea; Cambaridae; Procambarus.
A chromosome-level reference genome of red swamp crayfish Procambarus clarkii provides insights into the gene families regarding growth or development in crustaceans
REFSEQ INFORMATION: The reference sequence is identical to\nCM035545.1.\nAssembly name: ASM2042438v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Freshwater Fisheries Research\nInstitute of Jiangsu Province, Nanjing 210017, China on 2021/10/12.\nThe original whole-genome shotgun project has the accession\nJAIWQB000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Freshwater Fisheries Research Institute\n of Jiangsu Province, Nanjing 210017,\n China\nAssembly Method :: LACHESIS v. may-2020\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100.0x\nSequencing Technology :: PacBio RS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Procambarus clarkii Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
lysine-rich arabinogalactan protein 19-like
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
heat shock protein 75 kDa, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X1
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X2
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
serine/arginine repetitive matrix protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123773312, transcript variant X3
uncharacterized LOC123773312, transcript variant X5
uncharacterized LOC123773312, transcript variant X2
uncharacterized LOC123773312, transcript variant X1
uncharacterized LOC123773312, transcript variant X4
putative deoxyribonuclease TATDN1, transcript variant X6
putative deoxyribonuclease TATDN1, transcript variant X3
putative deoxyribonuclease TATDN1, transcript variant X4
putative deoxyribonuclease TATDN1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
putative deoxyribonuclease TATDN1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
putative deoxyribonuclease TATDN1, transcript variant X5
putative deoxyribonuclease TATDN1 isoform X2
uncharacterized protein LOC123773313 isoform X1
putative deoxyribonuclease TATDN1 isoform X3
uncharacterized PE-PGRS family protein PE_PGRS54-like
low-density lipoprotein receptor-related protein 2-like, transcript variant X1
low-density lipoprotein receptor-related protein 2-like, transcript variant X2
low-density lipoprotein receptor-related protein 2-like, transcript variant X3
low-density lipoprotein receptor-related protein 2-like, transcript variant X4
low-density lipoprotein receptor-related protein 2-like, transcript variant X5
low-density lipoprotein receptor-related protein 2-like isoform X1
low-density lipoprotein receptor-related protein 2-like isoform X2
low-density lipoprotein receptor-related protein 2-like isoform X3
low-density lipoprotein receptor-related protein 2-like isoform X4
low-density lipoprotein receptor-related protein 2-like isoform X5
DNA fragmentation factor subunit alpha-like, transcript variant X4
DNA fragmentation factor subunit alpha-like, transcript variant X2
DNA fragmentation factor subunit alpha-like, transcript variant X3
DNA fragmentation factor subunit alpha-like, transcript variant X5
DNA fragmentation factor subunit alpha-like, transcript variant X1
DNA fragmentation factor subunit alpha-like
leukocyte elastase inhibitor-like, transcript variant X2
leukocyte elastase inhibitor-like, transcript variant X1
leukocyte elastase inhibitor-like isoform X1
leukocyte elastase inhibitor-like isoform X2
transcription initiation factor TFIID subunit 2-like
thioredoxin domain-containing protein 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP10-like
adenylate cyclase type 2-like, transcript variant X2
adenylate cyclase type 2-like, transcript variant X3
adenylate cyclase type 2-like, transcript variant X1
adenylate cyclase type 2-like, transcript variant X4
adenylate cyclase type 2-like isoform X2
adenylate cyclase type 2-like isoform X3
adenylate cyclase type 2-like isoform X1
adenylate cyclase type 2-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
actin-related protein 6-like, transcript variant X2
actin-related protein 6-like, transcript variant X1
actin-related protein 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
major facilitator superfamily domain-containing protein 9-like, transcript variant X5
major facilitator superfamily domain-containing protein 9-like, transcript variant X2
major facilitator superfamily domain-containing protein 9-like, transcript variant X1
major facilitator superfamily domain-containing protein 9-like, transcript variant X3
major facilitator superfamily domain-containing protein 9-like, transcript variant X4
major facilitator superfamily domain-containing protein 9-like, transcript variant X7
major facilitator superfamily domain-containing protein 9-like, transcript variant X6
major facilitator superfamily domain-containing protein 9-like, transcript variant X8
major facilitator superfamily domain-containing protein 9-like isoform X3
major facilitator superfamily domain-containing protein 9-like isoform X1
major facilitator superfamily domain-containing protein 9-like isoform X2
major facilitator superfamily domain-containing protein 9-like isoform X4
major facilitator superfamily domain-containing protein 9-like isoform X5
cytosolic purine 5'-nucleotidase-like, transcript variant X1
cytosolic purine 5'-nucleotidase-like, transcript variant X2
cytosolic purine 5'-nucleotidase-like, transcript variant X8
cytosolic purine 5'-nucleotidase-like isoform X1
cytosolic purine 5'-nucleotidase-like, transcript variant X5
cytosolic purine 5'-nucleotidase-like, transcript variant X6
cytosolic purine 5'-nucleotidase-like, transcript variant X7
cytosolic purine 5'-nucleotidase-like isoform X4
cytosolic purine 5'-nucleotidase-like, transcript variant X3
cytosolic purine 5'-nucleotidase-like isoform X2
cytosolic purine 5'-nucleotidase-like, transcript variant X10
cytosolic purine 5'-nucleotidase-like, transcript variant X9
cytosolic purine 5'-nucleotidase-like isoform X5
cytosolic purine 5'-nucleotidase-like, transcript variant X4
cytosolic purine 5'-nucleotidase-like isoform X3
cytosolic purine 5'-nucleotidase-like, transcript variant X11
cytosolic purine 5'-nucleotidase-like isoform X6
cytosolic purine 5'-nucleotidase-like isoform X7
E3 ubiquitin-protein ligase AMFR-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase AMFR-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
E3 ubiquitin-protein ligase AMFR-like isoform X1
E3 ubiquitin-protein ligase AMFR-like isoform X2
lysophosphatidylserine lipase ABHD12-like, transcript variant X3
lysophosphatidylserine lipase ABHD12-like, transcript variant X4
lysophosphatidylserine lipase ABHD12-like, transcript variant X2
lysophosphatidylserine lipase ABHD12-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
lysophosphatidylserine lipase ABHD12-like, transcript variant X1
lysophosphatidylserine lipase ABHD12-like isoform X1
lysophosphatidylserine lipase ABHD12-like isoform X2
uncharacterized LOC123773334, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC123773334, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123773336, transcript variant X2
uncharacterized LOC123773336, transcript variant X1
organic cation transporter protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
organic cation transporter protein-like isoform X1
organic cation transporter protein-like isoform X3
organic cation transporter protein-like isoform X2
carboxy-terminal kinesin 2-like, transcript variant X2
carboxy-terminal kinesin 2-like, transcript variant X1
potassium voltage-gated channel protein Shaker-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like isoform X1
potassium voltage-gated channel protein Shaker-like isoform X2
potassium voltage-gated channel protein Shaker-like isoform X5
potassium voltage-gated channel protein Shaker-like isoform X4
potassium voltage-gated channel protein Shaker-like isoform X3
potassium voltage-gated channel protein Shaker-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium voltage-gated channel protein Shaker-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
SH3 domain-containing protein C23A1.17-like
ankyrin repeat and BTB/POZ domain-containing protein 2-like, transcript variant X1
ankyrin repeat and BTB/POZ domain-containing protein 2-like, transcript variant X2
ankyrin repeat and BTB/POZ domain-containing protein 2-like
uncharacterized LOC123773345, transcript variant X2
uncharacterized LOC123773345, transcript variant X1
transient receptor potential channel pyrexia-like, transcript variant X2
transient receptor potential channel pyrexia-like, transcript variant X1
transient receptor potential channel pyrexia-like isoform X1
transient receptor potential channel pyrexia-like isoform X2
proton-coupled amino acid transporter 4-like, transcript variant X2
proton-coupled amino acid transporter 4-like, transcript variant X3
proton-coupled amino acid transporter 4-like, transcript variant X4
proton-coupled amino acid transporter 4-like, transcript variant X1
proton-coupled amino acid transporter 4-like isoform X1
proton-coupled amino acid transporter 4-like isoform X2
pleckstrin homology-like domain family B member 1, transcript variant X1
pleckstrin homology-like domain family B member 1, transcript variant X3
pleckstrin homology-like domain family B member 1, transcript variant X2
pleckstrin homology-like domain family B member 1, transcript variant X4
pleckstrin homology-like domain family B member 1 isoform X1
pleckstrin homology-like domain family B member 1 isoform X3
pleckstrin homology-like domain family B member 1 isoform X2
pleckstrin homology-like domain family B member 1 isoform X4
pleckstrin homology-like domain family B member 1, transcript variant X9
pleckstrin homology-like domain family B member 1, transcript variant X6
pleckstrin homology-like domain family B member 1, transcript variant X5
pleckstrin homology-like domain family B member 1, transcript variant X7
pleckstrin homology-like domain family B member 1, transcript variant X8
pleckstrin homology-like domain family B member 1, transcript variant X10
pleckstrin homology-like domain family B member 2 isoform X5
uncharacterized LOC123773354, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123773354, transcript variant X2
uncharacterized LOC123773354, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
tetratricopeptide repeat protein 7B-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123773359, transcript variant X3
uncharacterized LOC123773359, transcript variant X2
uncharacterized LOC123773359, transcript variant X1
magnetosome-associated protein MamJ-like
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X4
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X1
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X2
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X3
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X5
GDP-fucose protein O-fucosyltransferase 2-like
CCR4-NOT transcription complex subunit 2-like, transcript variant X4
CCR4-NOT transcription complex subunit 2-like, transcript variant X3
CCR4-NOT transcription complex subunit 2-like, transcript variant X2
CCR4-NOT transcription complex subunit 2-like, transcript variant X1
CCR4-NOT transcription complex subunit 2-like, transcript variant X5
CCR4-NOT transcription complex subunit 2-like isoform X3
CCR4-NOT transcription complex subunit 2-like isoform X2
CCR4-NOT transcription complex subunit 2-like isoform X1
CCR4-NOT transcription complex subunit 2-like isoform X4
putative Kunitz-type serine protease inhibitor
poly(A) polymerase type 3-like, transcript variant X4
poly(A) polymerase type 3-like, transcript variant X1
poly(A) polymerase type 3-like, transcript variant X3
poly(A) polymerase type 3-like, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X1
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X4
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X5
calcium-binding mitochondrial carrier protein SCaMC-3-like, transcript variant X6
calcium-binding mitochondrial carrier protein SCaMC-3-like isoform X3
calcium-binding mitochondrial carrier protein SCaMC-3-like isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2-like isoform X4
calcium-binding mitochondrial carrier protein SCaMC-2-like isoform X2
calcium-binding mitochondrial carrier protein SCaMC-2-like isoform X6
calcium-binding mitochondrial carrier protein SCaMC-2-like isoform X5
golgin subfamily A member 2-like, transcript variant X3
golgin subfamily A member 2-like, transcript variant X2
golgin subfamily A member 2-like, transcript variant X1
golgin subfamily A member 2-like, transcript variant X6
golgin subfamily A member 2-like, transcript variant X4
golgin subfamily A member 2-like, transcript variant X5
golgin subfamily A member 2-like isoform X5
golgin subfamily A member 2-like isoform X2
golgin subfamily A member 2-like isoform X3
golgin subfamily A member 2-like isoform X1
golgin subfamily A member 2-like isoform X4
regulator of G-protein signaling 7-like, transcript variant X3
regulator of G-protein signaling 7-like, transcript variant X4
regulator of G-protein signaling 7-like, transcript variant X1
regulator of G-protein signaling 7-like, transcript variant X5
regulator of G-protein signaling 7-like, transcript variant X2
regulator of G-protein signaling 7-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
regulator of G-protein signaling 7-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
regulator of G-protein signaling 7-like isoform X1
regulator of G-protein signaling 7-like isoform X3
regulator of G-protein signaling 7-like isoform X2
transcription termination factor 2-like, transcript variant X2
transcription termination factor 2-like, transcript variant X1
transcription termination factor 2-like isoform X2
transcription termination factor 2-like isoform X1
ZZ-type zinc finger-containing protein 3-like, transcript variant X5
ZZ-type zinc finger-containing protein 3-like, transcript variant X4
ZZ-type zinc finger-containing protein 3-like, transcript variant X2
ZZ-type zinc finger-containing protein 3-like, transcript variant X3
ZZ-type zinc finger-containing protein 3-like, transcript variant X6
ZZ-type zinc finger-containing protein 3-like, transcript variant X1
ZZ-type zinc finger-containing protein 3-like isoform X3
ZZ-type zinc finger-containing protein 3-like isoform X1
ZZ-type zinc finger-containing protein 3-like isoform X2
formin-like protein, transcript variant X1
formin-like protein, transcript variant X2
formin-like protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
formin-like protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
formin-like protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
formin-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial genome maintenance exonuclease 1-like, transcript variant X1
mitochondrial genome maintenance exonuclease 1-like, transcript variant X2
mitochondrial genome maintenance exonuclease 1-like, transcript variant X3
mitochondrial genome maintenance exonuclease 1-like, transcript variant X4
mitochondrial genome maintenance exonuclease 1-like
mediator of RNA polymerase II transcription subunit 16-like
uncharacterized LOC123773378, transcript variant X1
uncharacterized LOC123773378, transcript variant X2
5'-AMP-activated protein kinase catalytic subunit alpha-2-like, transcript variant X1
5'-AMP-activated protein kinase catalytic subunit alpha-2-like, transcript variant X2
5'-AMP-activated protein kinase catalytic subunit alpha-2-like isoform X1
5'-AMP-activated protein kinase catalytic subunit alpha-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cyclin-D1-binding protein 1 homolog, transcript variant X4
cyclin-D1-binding protein 1 homolog, transcript variant X2
cyclin-D1-binding protein 1 homolog, transcript variant X1
cyclin-D1-binding protein 1 homolog, transcript variant X3
cyclin-D1-binding protein 1 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123773385, transcript variant X3
uncharacterized LOC123773385, transcript variant X1
uncharacterized LOC123773385, transcript variant X2
uncharacterized protein LOC123773385 isoform X1
uncharacterized protein LOC123773385 isoform X2
uncharacterized LOC123773384, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123773384, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123773384, transcript variant X1
uncharacterized protein LOC123773384 isoform X2
uncharacterized protein LOC123773384 isoform X1
serine/threonine-protein phosphatase with EF-hands 2-like
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GARH01021935.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 158 bases not found in genome assembly
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 156 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
probable 26S proteasome non-ATPase regulatory subunit 3
calcium-dependent secretion activator-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein DKFZp434B061-like
hexokinase type 2-like, transcript variant X1
hexokinase type 2-like, transcript variant X2
hexokinase type 2-like, transcript variant X3
hexokinase type 2-like, transcript variant X4
putative GPI-anchor transamidase, transcript variant X2
putative GPI-anchor transamidase, transcript variant X4
putative GPI-anchor transamidase, transcript variant X1
putative GPI-anchor transamidase, transcript variant X3
CCR4-NOT transcription complex subunit 3-like, transcript variant X6
CCR4-NOT transcription complex subunit 3-like, transcript variant X2
CCR4-NOT transcription complex subunit 3-like, transcript variant X5
CCR4-NOT transcription complex subunit 3-like, transcript variant X4
CCR4-NOT transcription complex subunit 3-like, transcript variant X1
CCR4-NOT transcription complex subunit 3-like, transcript variant X3
CCR4-NOT transcription complex subunit 3-like, transcript variant X8
CCR4-NOT transcription complex subunit 3-like, transcript variant X7
CCR4-NOT transcription complex subunit 3-like, transcript variant X10
CCR4-NOT transcription complex subunit 3-like, transcript variant X9
CCR4-NOT transcription complex subunit 3-like isoform X6
CCR4-NOT transcription complex subunit 3-like isoform X2
CCR4-NOT transcription complex subunit 3-like isoform X5
CCR4-NOT transcription complex subunit 3-like isoform X4
CCR4-NOT transcription complex subunit 3-like isoform X1
CCR4-NOT transcription complex subunit 3-like isoform X3
CCR4-NOT transcription complex subunit 3-like isoform X7
39S ribosomal protein L40, mitochondrial-like
39S ribosomal protein L27, mitochondrial-like
uncharacterized LOC123773400, transcript variant X1
uncharacterized LOC123773400, transcript variant X3
uncharacterized LOC123773400, transcript variant X5
uncharacterized LOC123773400, transcript variant X2
uncharacterized LOC123773400, transcript variant X4
uncharacterized protein LOC123773400 isoform X1
uncharacterized protein LOC123773400 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
endophilin-B1-like, transcript variant X3
endophilin-B1-like, transcript variant X1
endophilin-B1-like, transcript variant X2
cyclin-dependent kinase inhibitor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cyclin-dependent kinase inhibitor 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin-dependent kinase inhibitor 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
cyclin-dependent kinase inhibitor 3-like isoform X1
cyclin-dependent kinase inhibitor 3-like isoform X2
uncharacterized LOC123773406, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123773406, transcript variant X3
uncharacterized LOC123773406, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized LOC123773406, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
meiotic nuclear division protein 1 homolog, transcript variant X6
meiotic nuclear division protein 1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123773408, transcript variant X2
uncharacterized LOC123773408, transcript variant X1
meiotic nuclear division protein 1 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
meiotic nuclear division protein 1 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
meiotic nuclear division protein 1 homolog, transcript variant X3
meiotic nuclear division protein 1 homolog, transcript variant X2
meiotic nuclear division protein 1 homolog isoform X2
meiotic nuclear division protein 1 homolog isoform X1
ethanolamine-phosphate phospho-lyase-like
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
5-phosphohydroxy-L-lysine phospho-lyase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123773413, transcript variant X2
uncharacterized LOC123773413, transcript variant X1
uncharacterized protein LOC123773413 isoform X1
uncharacterized protein LOC123773413 isoform X2
uncharacterized LOC123773424, transcript variant X3
uncharacterized LOC123773424, transcript variant X1
uncharacterized LOC123773424, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
fork head domain transcription factor slp1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized LOC123773427, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123773427, transcript variant X2
uncharacterized LOC123773429, transcript variant X2
uncharacterized LOC123773429, transcript variant X1
uncharacterized LOC123773428, transcript variant X2
uncharacterized LOC123773428, transcript variant X1
zinc finger protein OZF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
tumor protein p53-inducible protein 11-like, transcript variant X1
tumor protein p53-inducible protein 11-like, transcript variant X3
tumor protein p53-inducible protein 11-like, transcript variant X2
tumor protein p53-inducible protein 11-like isoform X1
tumor protein p53-inducible protein 11-like isoform X3
tumor protein p53-inducible protein 11-like isoform X2
leucine-rich repeat extensin-like protein 5
mitochondrial glutamate carrier 1-like, transcript variant X2
mitochondrial glutamate carrier 1-like, transcript variant X1
mitochondrial glutamate carrier 1-like, transcript variant X3
integrator complex subunit 6-A-like, transcript variant X1
integrator complex subunit 6-A-like, transcript variant X4
integrator complex subunit 6-A-like, transcript variant X3
integrator complex subunit 6-A-like, transcript variant X2
integrator complex subunit 6-A-like isoform X1
integrator complex subunit 6-A-like isoform X2
integrator complex subunit 6-A-like isoform X3
deoxyribodipyrimidine photo-lyase-like, transcript variant X3
deoxyribodipyrimidine photo-lyase-like, transcript variant X4
deoxyribodipyrimidine photo-lyase-like, transcript variant X1
deoxyribodipyrimidine photo-lyase-like, transcript variant X2
deoxyribodipyrimidine photo-lyase-like isoform X1
deoxyribodipyrimidine photo-lyase-like, transcript variant X5
deoxyribodipyrimidine photo-lyase-like isoform X2
uncharacterized LOC123773439, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
uncharacterized LOC123773439, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
uncharacterized LOC123773439, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 98 samples with support for all annotated introns
uncharacterized LOC123773439, transcript variant X4
uncharacterized LOC123773439, transcript variant X5
uncharacterized LOC123773439, transcript variant X6
tetra-peptide repeat homeobox protein 1-like
protein lava lamp-like, transcript variant X4
protein lava lamp-like, transcript variant X3
protein lava lamp-like, transcript variant X2
protein lava lamp-like, transcript variant X1
uncharacterized protein LOC123773440 isoform X2
uncharacterized protein LOC123773440 isoform X1
protein lava lamp-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein lava lamp-like, transcript variant X5
protein lava lamp-like, transcript variant X6
protein lava lamp-like, transcript variant X8
protein lava lamp-like, transcript variant X7
phenazine biosynthesis-like domain-containing protein, transcript variant X1
phenazine biosynthesis-like domain-containing protein, transcript variant X3
phenazine biosynthesis-like domain-containing protein, transcript variant X2
phenazine biosynthesis-like domain-containing protein
spectrin beta chain, non-erythrocytic 1-like, transcript variant X3
spectrin beta chain, non-erythrocytic 1-like, transcript variant X2
spectrin beta chain, non-erythrocytic 1-like, transcript variant X4
spectrin beta chain, non-erythrocytic 1-like, transcript variant X6
spectrin beta chain, non-erythrocytic 1-like, transcript variant X8
spectrin beta chain, non-erythrocytic 1-like, transcript variant X5
spectrin beta chain, non-erythrocytic 1-like, transcript variant X9
spectrin beta chain, non-erythrocytic 1-like, transcript variant X7
spectrin beta chain, non-erythrocytic 1-like, transcript variant X12
spectrin beta chain, non-erythrocytic 1-like, transcript variant X10
spectrin beta chain, non-erythrocytic 1-like, transcript variant X11
spectrin beta chain, non-erythrocytic 1-like, transcript variant X1
spectrin alpha chain, non-erythrocytic 1-like isoform X3
spectrin alpha chain, non-erythrocytic 1-like isoform X5
spectrin alpha chain, non-erythrocytic 1-like isoform X2
spectrin alpha chain, non-erythrocytic 1-like isoform X6
spectrin alpha chain, non-erythrocytic 1-like isoform X4
spectrin beta chain, non-erythrocytic 1-like isoform X9
spectrin beta chain, non-erythrocytic 1-like isoform X7
spectrin alpha chain, non-erythrocytic 1-like isoform X8
spectrin alpha chain, non-erythrocytic 1-like isoform X1
spectrin beta chain, non-erythrocytic 1-like, transcript variant X13
spectrin alpha chain, non-erythrocytic 1-like isoform X10
microfibril-associated glycoprotein 4-like
cilia- and flagella-associated protein 57-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 3-like, transcript variant X1
CAP-Gly domain-containing linker protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 4-like isoform X1
CAP-Gly domain-containing linker protein 3-like isoform X2
tubulin alpha-3 chain, transcript variant X1
tubulin alpha-3 chain, transcript variant X2
uncharacterized LOC123773449, transcript variant X2
uncharacterized LOC123773449, transcript variant X1
uncharacterized protein LOC123773449 isoform X2
uncharacterized protein LOC123773449 isoform X1
crossover junction endonuclease EME1-like, transcript variant X2
crossover junction endonuclease EME1-like, transcript variant X6
crossover junction endonuclease EME1-like, transcript variant X1
crossover junction endonuclease EME1-like, transcript variant X4
crossover junction endonuclease EME1-like, transcript variant X5
crossover junction endonuclease EME1-like, transcript variant X3
crossover junction endonuclease EME1-like, transcript variant X7
crossover junction endonuclease EME1-like isoform X1
crossover junction endonuclease EME1-like isoform X2
crossover junction endonuclease EME1-like isoform X3
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like, transcript variant X2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like, transcript variant X1
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like, transcript variant X3
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like isoform X1
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like isoform X3
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like isoform X2
OTU domain-containing protein 3-like, transcript variant X2
OTU domain-containing protein 3-like, transcript variant X3
OTU domain-containing protein 3-like, transcript variant X1
serine/threonine-protein kinase Pink1, mitochondrial-like, transcript variant X1
serine/threonine-protein kinase Pink1, mitochondrial-like, transcript variant X2
serine/threonine-protein kinase Pink1, mitochondrial-like isoform X1
serine/threonine-protein kinase Pink1, mitochondrial-like isoform X2
putative defense protein Hdd11-like, transcript variant X3
putative defense protein Hdd11-like, transcript variant X1
putative defense protein Hdd11-like, transcript variant X2
putative defense protein Hdd11-like isoform X1
uncharacterized LOC123773463, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC123773463, transcript variant X1
uncharacterized LOC123773463, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
GATOR complex protein WDR59-like, transcript variant X3
GATOR complex protein WDR59-like, transcript variant X1
GATOR complex protein WDR59-like, transcript variant X2
GATOR complex protein WDR59-like, transcript variant X4
GATOR complex protein WDR59-like isoform X4
GATOR complex protein WDR59-like isoform X3
GATOR complex protein WDR59-like isoform X1
GATOR complex protein WDR59-like isoform X2
serine/threonine-protein kinase PLK1-like
actin-related protein 2/3 complex subunit 5-C-like
60S ribosomal protein L35-like, transcript variant X2
60S ribosomal protein L35-like isoform X2
60S ribosomal protein L35-like, transcript variant X1
60S ribosomal protein L35-like isoform X1
uncharacterized LOC123773470, transcript variant X4
uncharacterized LOC123773470, transcript variant X2
uncharacterized LOC123773470, transcript variant X1
uncharacterized LOC123773470, transcript variant X3
HAUS augmin-like complex subunit 1, transcript variant X5
HAUS augmin-like complex subunit 1, transcript variant X3
HAUS augmin-like complex subunit 1, transcript variant X1
HAUS augmin-like complex subunit 1, transcript variant X4
HAUS augmin-like complex subunit 1, transcript variant X2
GTP-binding nuclear protein GSP2/CNR2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
uncharacterized LOC123773476, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC123773476, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
serine/arginine repetitive matrix protein 2-like
uncharacterized LOC123773471, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123773471, transcript variant X3
uncharacterized LOC123773471, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein LOC123773471 isoform X1
uncharacterized protein LOC123773471 isoform X2
uncharacterized protein LOC123773471 isoform X3
uncharacterized LOC123773477, transcript variant X4
uncharacterized LOC123773477, transcript variant X2
uncharacterized LOC123773477, transcript variant X1
uncharacterized LOC123773477, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X7
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X6
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X10
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X8
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X9
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X3
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X4
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like, transcript variant X5
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like isoform X8
uncharacterized protein LOC123773478 isoform X4
uncharacterized protein LOC123773478 isoform X7
uncharacterized protein LOC123773478 isoform X5
uncharacterized protein LOC123773478 isoform X3
uncharacterized protein LOC123773478 isoform X1
uncharacterized protein LOC123773478 isoform X2
TATA-binding protein-associated factor 2N-like, transcript variant X2
TATA-binding protein-associated factor 2N-like, transcript variant X1
TATA-binding protein-associated factor 2N-like isoform X2
TATA-binding protein-associated factor 2N-like isoform X1
phosphatidylserine decarboxylase proenzyme, mitochondrial-like, transcript variant X1
phosphatidylserine decarboxylase proenzyme, mitochondrial-like, transcript variant X2
phosphatidylserine decarboxylase proenzyme, mitochondrial-like isoform X1
phosphatidylserine decarboxylase proenzyme, mitochondrial-like isoform X2
phosphatidylserine decarboxylase proenzyme, mitochondrial-like, transcript variant X3
phosphatidylserine decarboxylase proenzyme, mitochondrial-like isoform X3
phosphatidylserine decarboxylase proenzyme, mitochondrial-like, transcript variant X4
phosphatidylserine decarboxylase proenzyme, mitochondrial-like, transcript variant X5
phosphatidylserine decarboxylase proenzyme, mitochondrial-like isoform X4
oxysterol-binding protein-related protein 3-like, transcript variant X4
oxysterol-binding protein-related protein 3-like, transcript variant X1
oxysterol-binding protein-related protein 3-like, transcript variant X3
oxysterol-binding protein-related protein 3-like, transcript variant X2
oxysterol-binding protein-related protein 3-like isoform X1
oxysterol-binding protein-related protein 3-like isoform X2
oxysterol-binding protein-related protein 3-like isoform X3
oxysterol-binding protein-related protein 3-like, transcript variant X5
oxysterol-binding protein-related protein 3-like isoform X4
oxysterol-binding protein-related protein 6-like isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase H-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase H-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase H-like isoform X1
peptidyl-prolyl cis-trans isomerase H-like isoform X2
Golgi pH regulator-like, transcript variant X1
Golgi pH regulator-like, transcript variant X2
Golgi pH regulator-like, transcript variant X3
protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like
protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2-like, transcript variant X2
protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2-like, transcript variant X1
protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2-like isoform X1
protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2-like isoform X2
sterol regulatory element-binding protein cleavage-activating protein-like, transcript variant X3
sterol regulatory element-binding protein cleavage-activating protein-like, transcript variant X1
sterol regulatory element-binding protein cleavage-activating protein-like, transcript variant X2
sterol regulatory element-binding protein cleavage-activating protein-like
leucine-rich repeat extensin-like protein 5, transcript variant X1
leucine-rich repeat extensin-like protein 5, transcript variant X2
leucine-rich repeat extensin-like protein 5 isoform X2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns